Visual-ICE Cryoablation System
Total Payments
$179,449
Transactions
38
Doctors
9
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $6,599 | 20 | 6 |
| 2023 | $110.19 | 8 | 3 |
| 2022 | $172,740 | 10 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $172,740 | 10 | 96.3% |
| Travel and Lodging | $4,893 | 13 | 2.7% |
| Food and Beverage | $1,066 | 13 | 0.6% |
| Consulting Fee | $750.00 | 2 | 0.4% |
Payments by Type
Research
$172,740
10 transactions
General
$6,709
28 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Comparative Effectiveness of Cryoablation Using the ICE Seed Cryoablation Needle | BOSTON SCIENTIFIC CORPORATION | $55,475 | 0 |
| Pembrolizumab And Cryoablation In Urothelial Carcinoma | BOSTON SCIENTIFIC CORPORATION | $52,268 | 0 |
| PeriOperative Ipilimumab Nivolumab and Cryoablation in Women With Triple negative Breast Cancer | BOSTON SCIENTIFIC CORPORATION | $27,761 | 0 |
| Pembrolizumab With Liver Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases | BOSTON SCIENTIFIC CORPORATION | $14,364 | 0 |
| Tc99mMAA Bronchial Artery Injection During Bronchial Embolization for Pulmonary Mass Induced Hemoptysis for Dosimetry Planning | BOSTON SCIENTIFIC CORPORATION | $13,367 | 0 |
| A Pilot Study of Pembrolizumab and Liver Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients with Well Differentiated Neuroendocrine Tumors and Symptomatic and or Progressive Metastases | BOSTON SCIENTIFIC CORPORATION | $5,054 | 0 |
| Dendritic Cell Therapy Cryosurgery and Pembrolizumab in Treating Patients With Non Hodgkin Lymphoma | BOSTON SCIENTIFIC CORPORATION | $4,451 | 0 |
Top Doctors Receiving Payments for Visual-ICE Cryoablation System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $172,740 | 10 |
| , MD | Diagnostic Radiology | Los Angeles, CA | $1,641 | 4 |
| , MD | Diagnostic Neuroimaging | Chicago, IL | $1,603 | 4 |
| , M.D | Diagnostic Radiology | Los Angeles, CA | $1,366 | 5 |
| , MD | Pediatric Radiology | Memphis, TN | $1,189 | 4 |
| , M.D | Vascular & Interventional Radiology | Birmingham, AL | $750.00 | 2 |
| , MD, MMS | Diagnostic Radiology | Houston, TX | $55.10 | 4 |
| , MD | Diagnostic Radiology | College Station, TX | $48.46 | 1 |
| , M.D | Diagnostic Radiology | Houston, TX | $45.10 | 3 |
| , MD | Vascular & Interventional Radiology | Houston, TX | $9.99 | 1 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $172,740
- Boston Scientific Corporation $6,709
Product Information
- Type Device
- Total Payments $179,449
- Total Doctors 9
- Transactions 38
About Visual-ICE Cryoablation System
Visual-ICE Cryoablation System is a device associated with $179,449 in payments to 9 healthcare providers, recorded across 38 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2022 to 2024. In 2024, $6,599 was paid across 20 transactions to 6 doctors.
The most common payment nature for Visual-ICE Cryoablation System is "Unspecified" ($172,740, 96.3% of total).
Visual-ICE Cryoablation System is associated with 7 research studies, including "Comparative Effectiveness of Cryoablation Using the ICE Seed Cryoablation Needle" ($55,475).